Search Results
Matches for acronym ma
293
rows returned
Results are ranked by score and user rating. Use the quick vote buttons when a candidate clearly matches or clearly does not.
| Acronym | Full Name | Score | User Rating | Judge | Search |
|---|---|---|---|---|---|
| MA | methamphetamine | 34 | 11 |
|
|
| MA | megestrol acetate | 21 | 1 |
|
|
| MA | membrane antigen | 19 | 3 |
|
|
| MA | migraine with aura | 14 | 6 |
|
|
| MA | mental age | 12 | 6 |
|
|
| MA | matrix | 12 | 3 |
|
|
| MA | microalbuminuria | 11 | 2 |
|
|
| MA | matrix protein | 10 | 4 |
|
|
| MA | mandelic acid | 10 | 2 |
|
|
| MA | monoclonal antibodies | 9 | 6 |
|
|
| MA | motor activity | 8 | 4 |
|
|
| MA | methylamine | 8 | 3 |
|
|
| MA | mental arithmetic | 8 | 2 |
|
|
| MA | microagglutination | 7 | 3 |
|
|
| MA | maximum amplitude | 7 | 2 |
|
|
| MA | membrane antigens | 7 | 1 |
|
|
| MA | malonaldehyde | 7 | 0 |
|
|
| MA | maleic anhydride | 6 | 7 |
|
|
| MA | 2-mercaptoacetate | 5 | 7 |
|
|
| MA | macular amyloidosis | 5 | 4 |
|
|
| MA | microscopic agglutination | 5 | 2 |
|
|
| MA | medroxyprogesterone acetate (MPA) and megestrol acetate | 5 | 0 |
|
|
| MA | trans-muconic acid | 4 | 5 |
|
|
| MA | million years ago | 4 | 4 |
|
|
| MA | mycophenolic acid | 4 | 4 |
|
|
| MA | menstrual age | 4 | 3 |
|
|
| MA | methacrylic acid | 4 | 2 |
|
|
| MA | mercaptoacetate | 4 | 1 |
|
|
| MA | mean amplitude | 3 | 6 |
|
|
| MA | moving average | 3 | 5 |
|
|
| MA | methylarsonic acid | 3 | 5 |
|
|
| MA | metastatic adenocarcinoma | 3 | 5 |
|
|
| MA | medial amygdala | 3 | 4 |
|
|
| MA | avium | 3 | 4 |
|
|
| MA | Mexican Americans | 3 | 4 |
|
|
| MA | mandelic | 3 | 4 |
|
|
| MA | microbiological assay | 3 | 4 |
|
|
| MA | migraine with typical aura | 3 | 4 |
|
|
| MA | microagglutination test | 3 | 3 |
|
|
| MA | maximal amplitude | 3 | 3 |
|
|
| MA | macrophages | 3 | 3 |
|
|
| MA | mitotic activity | 3 | 2 |
|
|
| MA | monoadducts | 3 | 2 |
|
|
| MA | metabolic acidosis | 3 | 1 |
|
|
| MA | mesangial area | 2 | 7 |
|
|
| MA | Mexican-American | 2 | 7 |
|
|
| MA | mafenide acetate | 2 | 6 |
|
|
| MA | methionine and arginine | 2 | 5 |
|
|
| MA | Mycobacterium avium | 2 | 5 |
|
|
| MA | monoamine | 2 | 5 |
|
|
| MA | MDMA abusers | 2 | 5 |
|
|
| MA | (+)-methamphetamine | 2 | 5 |
|
|
| MA | mitral annulus | 2 | 4 |
|
|
| MA | Mexican American | 2 | 4 |
|
|
| MA | modified atmosphere | 2 | 4 |
|
|
| MA | mean age | 2 | 4 |
|
|
| MA | manual acupuncture | 2 | 4 |
|
|
| MA | maternal aggression | 2 | 4 |
|
|
| MA | mycotic aneurysm | 2 | 4 |
|
|
| MA | methanogenic archaea | 2 | 3 |
|
|
| MA | metabolite N-demethyldiltiazem | 2 | 3 |
|
|
| MA | Maternal arterial blood | 2 | 3 |
|
|
| MA | macroalbumin | 2 | 3 |
|
|
| MA | maternal arterial | 2 | 3 |
|
|
| MA | methyl acrylate | 2 | 2 |
|
|
| MA | meglumine antimoniate | 2 | 2 |
|
|
| MA | N-methylaniline | 2 | 2 |
|
|
| MA | 5'-monodeiodinating activity | 2 | 1 |
|
|
| MA | middle-aged | 2 | 1 |
|
|
| MA | mixed agglutination | 2 | 1 |
|
|
| MA | mitotic apparatus | 2 | 0 |
|
|
| MA | mesenteric arteries | 2 | -1 |
|
|
| MA | most-affected | 1 | 9 |
|
|
| MA | mycotic aneurysms | 1 | 9 |
|
|
| MA | Motility Assay | 1 | 8 |
|
|
| MA | melamine | 1 | 7 |
|
|
| MA | marine alga | 1 | 7 |
|
|
| MA | monoclonal antibody | 1 | 7 |
|
|
| MA | musk ambrette | 1 | 7 |
|
|
| MA | mixed anhydride | 1 | 7 |
|
|
| MA | muscle actin | 1 | 6 |
|
|
| MA | muscarinic anticholinergic | 1 | 6 |
|
|
| MA | minimal attention condition | 1 | 6 |
|
|
| MA | microsatellite alteration | 1 | 6 |
|
|
| MA | mothers of non-disabled children | 1 | 6 |
|
|
| MA | MK-801 blocks the ability of D-methamphetamine | 1 | 6 |
|
|
| MA | metastatic activity | 1 | 6 |
|
|
| MA | muscular coordination | 1 | 6 |
|
|
| MA | milliamperage | 1 | 6 |
|
|
| MA | metabolism) of [14C]methylammonium | 1 | 6 |
|
|
| MA | mouse strains with (129/Sv-ter) and without | 1 | 6 |
|
|
| MA | moving average (ARMA) and moving average | 1 | 6 |
|
|
| MA | muramic acid | 1 | 6 |
|
|
| MA | D-mannitol | 1 | 6 |
|
|
| MA | arthritidis | 1 | 6 |
|
|
| MA | maternal femoral arterial | 1 | 6 |
|
|
| MA | maximum aggregation | 1 | 6 |
|
|
| MA | maximal acceleration | 1 | 6 |
|
|
| MA | mammary adenocarcinomas | 1 | 6 |
|
|
| MA | medial nucleus of the amygdala | 1 | 6 |
|
|
| MA | metabolic alkalosis | 1 | 5 |
|
|
| MA | Mycoplasma agalactiae | 1 | 5 |
|
|
| MA | anti-membrane antigen | 1 | 5 |
|
|
| MA | myoelectrical activity | 1 | 5 |
|
|
| MA | maleic acid | 1 | 5 |
|
|
| MA | masking | 1 | 5 |
|
|
| MA | m-AMSA 200 mg/m2/day x 3 days | 1 | 5 |
|
|
| MA | f-C3 | 1 | 5 |
|
|
| MA | guanidino-methylated arginines | 1 | 5 |
|
|
| MA | metaphase assay | 1 | 5 |
|
|
| MA | Mood 'Activity | 1 | 5 |
|
|
| MA | morpholine analogue | 1 | 5 |
|
|
| MA | MI and mental arithmetic | 1 | 5 |
|
|
| MA | macrophage | 1 | 5 |
|
|
| MA | meridional amblyopia | 1 | 5 |
|
|
| MA | measuring area | 1 | 5 |
|
|
| MA | trans-muconaldehyde | 1 | 5 |
|
|
| MA | mesaconitine | 1 | 5 |
|
|
| MA | mixed application | 1 | 5 |
|
|
| MA | MMPI Psychopathic Deviate (PD) and Hypomania | 1 | 5 |
|
|
| MA | mesenteric artery | 1 | 5 |
|
|
| MA | malic acid | 1 | 5 |
|
|
| MA | Sorkin | 1 | 5 |
|
|
| MA | myristic acid | 1 | 5 |
|
|
| MA | [14C]Myristate | 1 | 5 |
|
|
| MA | mitochondria | 1 | 4 |
|
|
| MA | monamine | 1 | 4 |
|
|
| MA | monodeiodinating activity | 1 | 4 |
|
|
| MA | MK-801 can block methamphetamine | 1 | 4 |
|
|
| MA | muscle area | 1 | 4 |
|
|
| MA | malic | 1 | 4 |
|
|
| MA | mortality | 1 | 4 |
|
|
| MA | microaggregates | 1 | 4 |
|
|
| MA | mevalonic aciduria | 1 | 4 |
|
|
| MA | mevalonic acid | 1 | 4 |
|
|
| MA | macromolecular adducts | 1 | 4 |
|
|
| MA | microbiologic assay | 1 | 4 |
|
|
| MA | massive atherosclerosis | 1 | 4 |
|
|
| MA | moment arm | 1 | 4 |
|
|
| MA | middle-altitude | 1 | 4 |
|
|
| MA | Mid-trimester | 1 | 4 |
|
|
| MA | mash diet | 1 | 4 |
|
|
| MA | male-asymptomatic | 1 | 4 |
|
|
| MA | migraine with aura patients | 1 | 4 |
|
|
| MA | mild asthmatic | 1 | 4 |
|
|
| MA | Massachusetts | 1 | 4 |
|
|
| MA | Ministry of Agriculture | 1 | 4 |
|
|
| MA | microsatellite analysis | 1 | 4 |
|
|
| MA | monoaural | 1 | 4 |
|
|
| MA | marine microalgal product | 1 | 4 |
|
|
| MA | milliamperes | 1 | 4 |
|
|
| MA | microimmunofluorescence (Micro-IF) and microagglutination | 1 | 4 |
|
|
| MA | monoclonal amphetamine(A)/methamphetamine | 1 | 4 |
|
|
| MA | mixed atrophy | 1 | 4 |
|
|
| MA | macaque adapted | 1 | 4 |
|
|
| MA | metered-dose actuator device | 1 | 4 |
|
|
| MA | Müllerian aplasia | 1 | 4 |
|
|
| MA | mercaptopropionic acid | 1 | 4 |
|
|
| MA | LuÃÂs | 1 | 4 |
|
|
| MA | metabolizable acids | 1 | 4 |
|
|
| MA | muscular artery | 1 | 4 |
|
|
| MA | mutants by increasing the matrix protein | 1 | 4 |
|
|
| MA | 6B-methyl ester | 1 | 4 |
|
|
| MA | mean AgNOR area per nucleus | 1 | 4 |
|
|
| MA | Na-2-mercaptoacetate | 1 | 4 |
|
|
| MA | melengestrol acetate (MGA) and megestrol acetate | 1 | 4 |
|
|
| MA | mechanical allodynia | 1 | 4 |
|
|
| MA | measured in the agar | 1 | 4 |
|
|
| MA | methacrylic anhydride | 1 | 4 |
|
|
| MA | mental arithmetic exercise | 1 | 4 |
|
|
| MA | meperidine analgesia | 1 | 4 |
|
|
| MA | Mérinos d'Arles | 1 | 4 |
|
|
| MA | Meliacine | 1 | 4 |
|
|
| MA | multiple abscesses | 1 | 4 |
|
|
| MA | (DETBA)-malonaldehyde | 1 | 4 |
|
|
| MA | moving-average | 1 | 4 |
|
|
| MA | Matrix treatment model for methamphetamine | 1 | 4 |
|
|
| MA | medroxyprogesterone acetate (MPA) or megestrol acetate | 1 | 4 |
|
|
| MA | medullary area | 1 | 4 |
|
|
| MA | medication (nortriptyline) alone | 1 | 4 |
|
|
| MA | method | 1 | 4 |
|
|
| MA | maximal aggregation | 1 | 4 |
|
|
| MA | mucosal antigen | 1 | 4 |
|
|
| MA | MEL-adapted | 1 | 4 |
|
|
| MA | mental-age | 1 | 4 |
|
|
| MA | melanotic transplantable hamster melanoma of Bomirski | 1 | 4 |
|
|
| MA | Mucosal electrosensitivity | 1 | 4 |
|
|
| MA | N-monodemethyldiltiazem | 1 | 3 |
|
|
| MA | Na-mercaptoacetate | 1 | 3 |
|
|
| MA | OH-cyclophosphan-mamophosphatide | 1 | 3 |
|
|
| MA | malformed newborns | 1 | 3 |
|
|
| MA | malignant astrocytomas | 1 | 3 |
|
|
| MA | males | 1 | 3 |
|
|
| MA | modified atmospheres | 1 | 3 |
|
|
| MA | major metabolite N-desmethyl-DTZ | 1 | 3 |
|
|
| MA | machined and acid-etched surface | 1 | 3 |
|
|
| MA | MPC-co-methacrylic acid | 1 | 3 |
|
|
| MA | macronucleus | 1 | 3 |
|
|
| MA | MMPI Scales 9 | 1 | 3 |
|
|
| MA | morphometric analysis | 1 | 3 |
|
|
| MA | Multiple aberrations | 1 | 3 |
|
|
| MA | mouse-adapted | 1 | 3 |
|
|
| MA | morphine-produced analgesia | 1 | 3 |
|
|
| MA | morphine antinociception | 1 | 3 |
|
|
| MA | monoclonal antibody preparations | 1 | 3 |
|
|
| MA | multiple intracranial aneurysms | 1 | 3 |
|
|
| MA | major metabolites N-monodesmethyl DTZ | 1 | 3 |
|
|
| MA | d-(S)-methamphetamine | 1 | 3 |
|
|
| MA | myogenic autoregulation | 1 | 3 |
|
|
| MA | monkey kidney cells | 1 | 3 |
|
|
| MA | m-methoxy aniline | 1 | 3 |
|
|
| MA | meter angle | 1 | 3 |
|
|
| MA | microtiter agglutination | 1 | 3 |
|
|
| MA | mean apnoea duration | 1 | 3 |
|
|
| MA | mesonephric remnants | 1 | 3 |
|
|
| MA | methylation and acetylation | 1 | 3 |
|
|
| MA | microcytotoxicity assay | 1 | 3 |
|
|
| MA | microangiography | 1 | 3 |
|
|
| MA | mean amplitude of the turns | 1 | 3 |
|
|
| MA | metabolites N-demethyl-diltiazem | 1 | 3 |
|
|
| MA | mastocytoma P815 | 1 | 3 |
|
|
| MA | micro-arousals | 1 | 3 |
|
|
| MA | mice were 12 months old | 1 | 3 |
|
|
| MA | metabolites which included N-monodesmethyl DTZ | 1 | 3 |
|
|
| MA | matrix area | 1 | 3 |
|
|
| MA | metalloproteinase activity | 1 | 3 |
|
|
| MA | microtitre agglutination | 1 | 3 |
|
|
| MA | middle-aged ad libitum-fed | 1 | 3 |
|
|
| MA | middle-aged hearts | 1 | 3 |
|
|
| MA | medroxyprogesterone acetate | 1 | 3 |
|
|
| MA | mitotic apparatuses | 1 | 3 |
|
|
| MA | malt extract agar | 1 | 3 |
|
|
| MA | medium altitude | 1 | 3 |
|
|
| MA | mitomycin and doxorubicin | 1 | 3 |
|
|
| MA | Minimal abnormalities | 1 | 3 |
|
|
| MA | marginal analysis | 1 | 3 |
|
|
| MA | medial | 1 | 3 |
|
|
| MA | morphologically atretic | 1 | 3 |
|
|
| MA | milliamps | 1 | 3 |
|
|
| MA | marker channel of atrial sense events | 1 | 3 |
|
|
| MA | Menarcheal age | 1 | 3 |
|
|
| MA | MCA and the microscopic agglutination | 1 | 2 |
|
|
| MA | maximal amplitude of clot formation | 1 | 2 |
|
|
| MA | multiple aneurysms | 1 | 2 |
|
|
| MA | arterial | 1 | 2 |
|
|
| MA | muscle actins | 1 | 2 |
|
|
| MA | Mechanistic analysis | 1 | 2 |
|
|
| MA | migraine with (MO) or without aura | 1 | 2 |
|
|
| MA | meningococcal arthritis | 1 | 2 |
|
|
| MA | media containing 1 mM methylamine hydrochloride | 1 | 2 |
|
|
| MA | metabolites of monoamines | 1 | 2 |
|
|
| MA | metabolite | 1 | 2 |
|
|
| MA | muskulären Koordination | 1 | 2 |
|
|
| MA | methoxyacetic acid | 1 | 2 |
|
|
| MA | Methylacetimidate | 1 | 2 |
|
|
| MA | microalbuminuric | 1 | 2 |
|
|
| MA | microstimulation in either the masseter | 1 | 2 |
|
|
| MA | master athletes | 1 | 2 |
|
|
| MA | microalbumin | 1 | 2 |
|
|
| MA | microagglutination tests | 1 | 2 |
|
|
| MA | mg/kg in one day | 1 | 2 |
|
|
| MA | methylmalonic acid | 1 | 2 |
|
|
| MA | motor activity assessments | 1 | 2 |
|
|
| MA | moderate altitude | 1 | 2 |
|
|
| MA | methanol and acetic acid | 1 | 2 |
|
|
| MA | matrix protein region | 1 | 2 |
|
|
| MA | Methylaniline | 1 | 2 |
|
|
| MA | maltase | 1 | 2 |
|
|
| MA | metastasizing activity | 1 | 2 |
|
|
| MA | myotonic atrophy | 1 | 1 |
|
|
| MA | modestly active | 1 | 1 |
|
|
| MA | meconium antigen | 1 | 1 |
|
|
| MA | mild physical | 1 | 1 |
|
|
| MA | N-monodemethyl diltiazem | 1 | 1 |
|
|
| MA | Pathology | 1 | 1 |
|
|
| MA | moderately active | 1 | 1 |
|
|
| MA | mitral annular | 1 | 1 |
|
|
| MA | meta-analysis | 1 | 1 |
|
|
| MA | microdissected and assessed for microsatellite alterations | 1 | 1 |
|
|
| MA | matrix domain | 1 | 1 |
|
|
| MA | methylamphetamine | 1 | 1 |
|
|
| MA | metaraminol | 1 | 1 |
|
|
| MA | Matrigel and heparin | 1 | 1 |
|
|
| MA | metabolites in plasma were N-monodesmethyl diltiazem | 1 | 1 |
|
|
| MA | methyl acetimidate | 1 | 1 |
|
|
| MA | maximum accumulation | 1 | 0 |
|
|
| MA | medium similar to seminal plasma | 1 | 0 |
|
|
| MA | medium activity | 1 | 0 |
|
|
| MA | microaneurysms | 1 | 0 |
|
|
| MA | maternal artery | 1 | 0 |
|
|
| MA | monofunctionally alkylated DNA | 1 | 0 |
|
|
| MA | Fe(III)-mugineic acid | 1 | 0 |
|
|
| MA | mucinous adenocarcinoma | 1 | -1 |
|
Run A Search
Search either direction
By Acronym
By Full Name